JAAPA CME Post-Test June 2018
Hypertension Guideline Update: A New Guideline for a New Era
In the United States, hypertension affects about one-third of adults and contributes to one out of every seven deaths. Evidence-based treatment is associated with reductions in incidence of stroke, myocardial infarction, and heart failure as well as associated disability and death. This activity reviews the ACC/AHA Task Force on Clinical Practice Guidelines’ 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Key changes include reclassification of BP stages and lowering of hypertension treatment goals.
Preparing Patients for Biologic Medications for Dermatologic and Rheumatic Diseases
Psoriasis, psoriatic arthritis, and rheumatoid arthritis are prevalent conditions that often require a team of primary care and specialist healthcare professionals for the most optimum patient outcomes. Primary care providers can facilitate referrals to dermatology and rheumatology specialists by obtaining the needed screening workup for patients who need treatment with immunosuppressive therapies. This activity reviews tuberculosis screening, hepatitis screening, and vaccinations to be administered before patients begin biologic medications.